Metformin and Malignant Tumors: Not Over the Hill [Response to Letter]
Weiling Leng,1,* Juan Jiang,2,* Bing Chen,1 Qinan Wu3 1Endocrinology Department, The First Affiliated Hospital of the Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China; 2Endocrinology and Nephrology Department, Chongqing University Cancer Ho...
Saved in:
Main Authors: | Leng W, Jiang J, Chen B, Wu Q |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/4d4b7314b6b44630ae57461f54d7ea3d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin and Malignant Tumors: Not Over the Hill
by: Leng W, et al.
Published: (2021) -
Metformin and Malignant Tumors: Not Over the Hill: A Short Comment [Letter]
by: Rastmanesh R
Published: (2021) -
Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
by: Leng W, et al.
Published: (2021) -
An easily ignored factor for CAN-fine particulate exposure [Response to Letter]
by: Vasheghani M
Published: (2019) -
Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
by: Bruckbauer A, et al.
Published: (2013)